Opinion
Video
Author(s):
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Stay up to date on cancer updates, research and education
Trodelvy Plus Keytruda May Slow Progression in mTNBC
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
“Chillin’ Out” and Finding Our Cancer Community
The Treatment Journey of a Patient with CLL
Managing Cancer Demands With Flexibility and a Strategic Mindset
What Patients With Kidney Cancer Need to Know From ASCO GU